{"id":"NCT01564537","sponsor":"Takeda","briefTitle":"A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma","officialTitle":"A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Ixazomib (MLN9708) Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08-01","primaryCompletion":"2014-10-01","completion":"2022-02-08","firstPosted":"2012-03-28","resultsPosted":"2016-01-27","lastUpdate":"2023-03-10"},"enrollment":722,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Relapsed Multiple Myeloma","Refractory Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Ixazomib","otherNames":["MLN9708","NINLAROÂ®"]},{"type":"DRUG","name":"Lenalidomide","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ixazomib + Lenalidomide + Dexamethasone","type":"EXPERIMENTAL"},{"label":"Placebo + Lenalidomide + Dexamethasone","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the addition of oral ixazomib to the background therapy of lenalidomide and dexamethasone improves progression free survival (PFS) in participants with relapsed and/or refractory multiple myeloma (RRMM).","primaryOutcome":{"measure":"Progression Free Survival (PFS) as Assessed by the Independent Review Committee (IRC)","timeFrame":"From date of randomization until disease progression or death up to approximately 27 months (approximate median follow-up 15 months)","effectByArm":[{"arm":"Ixazomib+ Lenalidomide + Dexamethasone","deltaMin":20.6,"sd":null},{"arm":"Placebo + Lenalidomide + Dexamethasone","deltaMin":14.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.012"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":24,"countries":["United States","Canada"]},"refs":{"pmids":["34111952","32145111","29054911","28803351","28751562","28683766","27119237","27002117"],"seeAlso":["https://www.tourmalinetrialmm1.com/"]},"adverseEventsSummary":{"seriousAny":{"events":205,"n":361},"commonTop":["Diarrhoea","Anaemia","Constipation","Fatigue","Neutropenia"]}}